• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 64 of 100
A Tea-Party supporter protest outside th
FinanceThe 3 Best Health Care and Pharma Stocks for 2017—Whatever Happens to Obamacare
By Jen WiecznerDecember 1, 2016
Trump Deficit
HealthHouse Just Passed the Biggest Health Reform Bill Since Obamacare
By Sy MukherjeeNovember 30, 2016
LeadershipElizabeth Warren Is Slamming This Drug Approval Bill as ‘Extortion’
By The Associated Press and Michelle TohNovember 29, 2016
A vaccine for the Zika virus could come to market in as little as two years.
HealthUrgently Needed: A New Financial Model for Vaccine Development
By Clifton LeafNovember 28, 2016
LeadershipHouse to Vote on Bill Aimed at Speeding Approval of Drugs
By The Associated PressNovember 26, 2016
External Insulin Pump
HealthA New Innovation for Type 2 Diabetes
By Clifton LeafNovember 17, 2016
Squawk Box - Season 20
LeadershipBill Ackman Says Valeant Might Change Its Name to Fix Its Reputation
By ReutersNovember 11, 2016
FinanceDonald Trump’s Presidency Could Unleash a Pharma Merger Boom
By ReutersNovember 11, 2016
HealthBig Pharma Pulled Off Its Own Upset on Election Night
By Sy MukherjeeNovember 9, 2016
HealthPharma Stocks Are Soaring After Donald Trump’s Victory
By Reuters and Coins2Day EditorsNovember 9, 2016
Inside A Walgreens Boots Alliance Location Ahead Of Earnings Figures
TechWalgreens Sues Theranos for $140 Million for Breach of Contract
By Kia KokalitchevaNovember 8, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
HealthThis Bipartisan Group of Senators Is Asking Mylan to Reimburse the Military
By ReutersNovember 8, 2016
HealthThese Pharma Stocks Plunged on Reports of Pending Price Collusion Charges
By ReutersNovember 4, 2016
HealthFederal Prosecutors Reportedly Plan Major Price Fixing Suit Against Drug Makers
By Sy MukherjeeNovember 3, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
HealthValeant Is Being Sued Over the ‘Female Viagra’ Pill
By Reuters and Tekendra ParmarNovember 2, 2016
1...
  • 62
  • 63
  • 64
  • 65
  • 66
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.